Eledon Pharmaceuticals Aktie
WKN DE: A2QL00 / ISIN: US28617K1016
23.10.2023 13:34:48
|
Eledon Pharmaceuticals Appoints Eliezer Katz As Chief Medical Officer
(RTTNews) - Eledon Pharmaceuticals, Inc. (ELDN) announced on Monday that it has appointed Eliezer Katz as chief medical officer.
Katz is a transplant surgeon and was the chief medical officer of eGenesis. Prior to eGenesis he has held many senior roles in companies like Viela Bio, Horizon Therapeutics MedImmune Inc. and many more.
On Thursday, Eledon shares closed at $1.3, down 2.25% on Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eledon Pharmaceuticalsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Eledon Pharmaceuticalsmehr Analysen
Aktien in diesem Artikel
Eledon Pharmaceuticals | 3,12 | 1,96% |
|